| Application no. and date | 15808314.7 (espacenet) (Federated) (European Patent Register), 20151130 | | Patent/reg. no. and date | DK/EP 3227273, 20220209 | | Publication date | 20171011 | | Priority no. and date | US 201462086691 P, 20141202, US 201562248071 P, 20151029 | | EP pub. no. and date |
EP 3227273 20171011 | | Effective date | | | Applicant/owner | Minerva Neurosciences, Inc., 1601 Trapelo Road, Suite 286
Waltham, MA 02451 , US | | Applicant ref. no. | 1617228 | | Inventor | LUTHRINGER, Remy, 1601 Trapelo Road
Suite 284
Waltham, Massachusetts 02451, US,
OKUYAMA, Masahiro, Mitsubishi Tanabe Pharma Corporation
3-2-10 Dosho-machi
Chuo-ku
Osaka 541-8505, JP,
NOEL, Nadine, 27 Rue aux 4 Vents
68250 Rouffach, FR,
WERNER, Sandra, 1b rue de la Hollau
67540 Ostwald, FR | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/454 (2006.01) , A61K 9/00 (2006.01) , A61P 25/00 (2006.01) , C07D 401/06 (2006.01) | | Title | SAMMENSÆTNINGER, SOM OMFATTER 2-((1-(2(4-FLUORPHENYL)-2-OXOETHYL)PIPERIDIN-4-YL)METHYL)ISOINDOLIN-1-ON, TIL BEHANLDING AF SKIZOFRENI | | Int. application no. | US2015062985 | | Int. publication no. | WO2016089766 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
